Singapore - English - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - tacrolimus monohydrate eqv tacrolimus - ointment - 0.03g/100g - tacrolimus monohydrate eqv tacrolimus 0.03g/100g

Singapore - English - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - tacrolimus monohydrate eqv tacrolimus - ointment - 0.10g/100g - tacrolimus monohydrate eqv tacrolimus 0.10g/100g

European Union - English - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - other dermatological preparations - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.

Malta - English - Medicines Authority

meda pharmaceuticals limited - pimecrolimus - cream - pimecrolimus 10 mg/g - other dermatological preparations

Malta - English - Medicines Authority

glaxo smithkline uk limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - alitretinoin - soft capsule - alitretinoin 10 mg - other dermatological preparations

Malta - English - Medicines Authority

glaxo smithkline uk limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - alitretinoin - soft capsule - alitretinoin 30 mg - other dermatological preparations

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - oclacitinib maleate - agents for dermatitis, excluding corticosteroids - dogs - - treatment of pruritus associated with allergic dermatitis in dogs.- treatment of clinical manifestations of atopic dermatitis in dogs.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - lokivetmab - other dermatological preparations, agents for dermatitis, excluding corticosteroids - dogs - treatment of clinical manifestations of atopic dermatitis in dogs.

European Union - English - EMA (European Medicines Agency)

leo pharma a/s - tacrolimus - dermatitis, atopic - other dermatological preparations - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids.children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids.maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring four or more times per year) who have had an initial response to a maximum of six weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).

Canada - English - Health Canada

leo pharma inc - tacrolimus - ointment - 0.1% - tacrolimus 0.1% - misc. skin and mucous membrane agents